Kairos Pharma's ENV-105 aims to overcome resistance in CRPC and EGFR-mutant NSCLC, with key data releases expected in 2025.

As more companies moved to Oak Ridge, 2024 brought with it a steady stream of nuclear news coming out of the Knoxville region ...

Starting from comfort reads to kicking-my-feet-giggling romance to stimulating memoirs, there is a little bit for everyone ...